# Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions

> **NCT02006602** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 16 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Candesartan cilexetil (GW615775, Test formulation)
- **DRUG:** Candesartan cilexetil (Reference treatment)

## Key facts

- **NCT ID:** NCT02006602
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-13
- **Primary completion:** 2014-01-22
- **Final completion:** 2014-01-22
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02006602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02006602, "Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02006602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*